Ariel Graff
Ariel Graff
Verified email at - Homepage
Cited by
Cited by
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
Differential Effects of Aripiprazole on D 2 , 5-HT 2 , and 5-HT 1A Receptor Occupancy in Patients With Schizophrenia: A Triple …
D Mamo, A Graff, R Mizrahi, CM Shammi, F Romeyer, S Kapur
American Journal of Psychiatry 164 (9), 1411-1417, 2007
Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis
P León-Ortiz, R Favila, S Stephano, D Mamo, J Ramírez-Bermúdez, ...
Neuropsychopharmacology 36 (9), 1781-1791, 2011
Cerebral blood flow associated with creative performance: a comparative study
RA Chávez-Eakle, A Graff-Guerrero, JC García-Reyna, V Vaugier, ...
Neuroimage 38 (3), 519-528, 2007
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
S Moriguchi, A Takamiya, Y Noda, N Horita, M Wada, S Tsugawa, ...
Molecular psychiatry 24 (7), 952-964, 2019
Kynurenine pathway in depression: A systematic review and meta-analysis
K Ogyu, K Kubo, Y Noda, Y Iwata, S Tsugawa, Y Omura, M Wada, ...
Neuroscience & Biobehavioral Reviews 90, 16-25, 2018
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making
G Fervaha, A Graff-Guerrero, KK Zakzanis, G Foussias, O Agid, ...
Journal of psychiatric research 47 (11), 1590-1596, 2013
Kynurenic acid in schizophrenia: a systematic review and meta-analysis
E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ...
Schizophrenia bulletin 43 (4), 764-777, 2017
Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation
T Suzuki, G Remington, BH Mulsant, H Uchida, TK Rajji, A Graff-Guerrero, ...
Psychiatry research 197 (1-2), 1-6, 2012
The potential role of dopamine D3 receptor neurotransmission in cognition
S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ...
European Neuropsychopharmacology 23 (8), 799-813, 2013
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D 2 receptors: a PET study in schizophrenia
R Mizrahi, P Rusjan, O Agid, A Graff, DC Mamo, RB Zipursky, S Kapur
American Journal of Psychiatry 164 (4), 630-637, 2007
Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance …
C de la Fuente-Sandoval, P León-Ortiz, M Azcárraga, S Stephano, ...
JAMA psychiatry 70 (10), 1057-1066, 2013
Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia
NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ...
Frontiers in psychiatry 9, 622, 2018
Glutamate-mediated excitotoxicity in schizophrenia: a review
E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ...
European Neuropsychopharmacology 24 (10), 1591-1605, 2014
Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain
A Graff-Guerrero, J González-Olvera, A Fresán, D Gómez-Martín, ...
Cognitive Brain Research 25 (1), 153-160, 2005
Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis
H Uchida, H Takeuchi, A Graff-Guerrero, T Suzuki, K Watanabe, ...
Journal of clinical psychopharmacology 31 (4), 497-502, 2011
Motivational deficits and cognitive test performance in schizophrenia
G Fervaha, KK Zakzanis, G Foussias, A Graff-Guerrero, O Agid, ...
JAMA psychiatry 71 (9), 1058-1065, 2014
Individual determinants of COVID-19 vaccine hesitancy
P Gerretsen, J Kim, F Caravaggio, L Quilty, M Sanches, S Wells, ...
PloS one 16 (11), e0258462, 2021
Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation
M Menon, J Jensen, I Vitcu, A Graff-Guerrero, A Crawley, MA Smith, ...
Biological psychiatry 62 (7), 765-772, 2007
Treatment resistant schizophrenia and response to antipsychotics: a review
T Suzuki, G Remington, BH Mulsant, TK Rajji, H Uchida, A Graff-Guerrero, ...
Schizophrenia research 133 (1-3), 54-62, 2011
The system can't perform the operation now. Try again later.
Articles 1–20